Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday that its fourth quarter revenues rose 7 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, the company reported revenues of $16.0 million, up from $14.9 million in Q4 2016, and beating the analysts' consensus estimate of $15.6 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.